These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1663846)

  • 1. Phosphoribosylpyrophosphate synthetase in human erythrocytes: assay and kinetic studies using high-performance liquid chromatography.
    Sakuma R; Nishina T; Yamanaka H; Kamatani N; Nishioka K; Maeda M; Tsuji A
    Clin Chim Acta; 1991 Dec; 203(2-3):143-52. PubMed ID: 1663846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal activity of metabolic pathways involved in the formation and utilization of phosphoribosylpyrophosphate in erythrocytes of patients with primary metabolic gout.
    Sperling O; Boer P; Brosh S; Elazar E; Szeinberg A; de Vries A
    Nutr Metab; 1975; 18(4):217-23. PubMed ID: 172821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic evaluation of phosphoribosylpyrophosphate synthetase activities in hemolysates.
    Losman MJ; Hecker S; Woo S; Becker MA
    J Lab Clin Med; 1984 Jun; 103(6):932-43. PubMed ID: 6327865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.
    Becker MA
    J Clin Invest; 1976 Feb; 57(2):308-18. PubMed ID: 176178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased erythrocyte phosphoribosylpyrophosphate synthetase activity and impaired formation in thalassemia minor: a mechanism for decreased adenine nucleotide content.
    Zerez CR; Lachant NA; Tanaka KR
    J Lab Clin Med; 1989 Jul; 114(1):43-50. PubMed ID: 2544652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA; Losman MJ; Itkin P; Simkin PA
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spectrophotometric assay of 5-phosphoribosyl-1-pyrophosphate synthetase (PRPP) in erythrocyte lysate (author's transl)].
    Micheli V; Taddeo A
    Quad Sclavo Diagn; 1981 Jun; 17(2):209-15. PubMed ID: 6267652
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
    Zoref E; De Vries A; Sperling O
    J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human phosphoribosylpyrophosphate synthetase: radioimmunochemical quantitation in erythrocytes and fibroblasts.
    Itkin P; Woo S; Becker MA
    J Lab Clin Med; 1984 Jul; 104(1):96-109. PubMed ID: 6330252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gouty family with increased phosphoribosylpyrophosphate synthetase activity: case reports, familial studies, and kinetic studies of the abnormal enzyme.
    Akaoka I; Fujimori S; Kamatani N; Takeuchi F; Yano E; Nishida Y; Hashimoto A; Horiuchi Y
    J Rheumatol; 1981; 8(4):563-74. PubMed ID: 6271966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disorders associated with purine and pyrimidine metabolism.
    Edwards NL; Fox IH
    Spec Top Endocrinol Metab; 1984; 6():95-140. PubMed ID: 6098039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HPLC-linked assay of phosphoribosylpyrophosphate synthetase activity in the erythrocytes of adults and children with neurological disorders.
    Micheli V; Rocchigiani M; Pompucci G
    Clin Chim Acta; 1994 Jun; 227(1-2):79-86. PubMed ID: 7955424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylthioadenosine phosphorylase activity in human erythrocytes.
    Sahota A; Webster DR; Potter CF; Simmonds HA; Rodgers AV; Gibson T
    Clin Chim Acta; 1983 Mar; 128(2-3):283-90. PubMed ID: 6406103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoribosyl pyrophosphate synthetase and glutathione reductase in erythrocytes from hyperuricaemic and gout patients.
    Hardwell TR; Braven J; Shaw S; Whittaker M
    Clin Chim Acta; 1982 Dec; 126(3):217-26. PubMed ID: 6295664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phosphoribosylpyrophosphate synthetase anomalies in 2 cases of gout beginning at an early age].
    Lejeune E; Bouvier M; Mousson B; Llorca G; Baltassat P
    Rev Rhum Mal Osteoartic; 1979; 46(7-9):457-65. PubMed ID: 228383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple and sensitive method for estimating the concentration and synthesis of 5-phosphoribosyl 1-pyrophosphate in red blood cells.
    Tax WJ; Veerkamp JH
    Clin Chim Acta; 1977 Jul; 78(2):209-16. PubMed ID: 195752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Juvenile gout].
    Carcassi A
    Reumatismo; 1977; 29(2-3):96-100. PubMed ID: 212803
    [No Abstract]   [Full Text] [Related]  

  • 19. Human phosphoribosylpyrophosphate (PRPP) synthetase requirements for subunit aggregation.
    Losman MJ; Becker MA
    Adv Exp Med Biol; 1984; 165 Pt A():427-32. PubMed ID: 6326486
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical variability of the gouty diathesis.
    Arnold WJ; Simmons RA
    Adv Exp Med Biol; 1980; 122A():39-46. PubMed ID: 6252756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.